Faeth Therapeutics Inc. (FTH) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Faeth Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$19.20
+0.47% today
Market cap
$494M
Overall quality
56/100
Kronos AI 30-day
+24.8%
8 of 8 simulated paths end higher
Faeth Therapeutics Inc. (FTH) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $494M. It trades at $19.20, up 0.47% today. Its overall quality score is 56 out of 100, ranked against the whole US market. 12 analysts' average target of $57.45 implies +199.2% from today's price. Kronos AI's 30-day forecast is +24.8% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $57.45 |
| Low – high | $40.00 – $70.00 |
| Analysts | 12 |
| Upside to average | +199.2% |
Kronos AI 30-day forecast
| Expected close | $23.85 (+24.8%) |
| Likely range | +19.2% … +48.5% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 36 |
| Solvency | 83 |
| Growth | 50 |
| Overall | 56 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.